Atlas Trials

A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection

Clinical trial NCT04966234 · UNKNOWN

Trial details

NCT number
NCT04966234
Sponsor
Bambino Gesù Hospital and Research Institute
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cystic FibrosisAspergillosis
Start date
2021-04-22
Primary completion
2023-04-01
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.